The cGAS-STING pathway drives type I IFN immunopathology in COVID-19
cGAS-STING 경로는 COVID-19에서 I형 IFN 면역병리를 유발합니다
Article
[키워드] activate
addition
caused
cell death
cGAS
characterized
ChIP
Clinical outcome
Complication
Control
COVID-19
Critical
cyclic GMP
cytosolic
disease
DNA
Endothelial cell
endothelial cell damage
endothelial cells
IFNs
Immunity
immunopathology
IMPROVE
increase in
Infection
infection with SARS-CoV-2
Inflammation
interferon
interferons
interferons (IFNs
late phase
limit
lung
Lung inflammation
Lung pathology
Macrophage
macrophages
Manifestations
mice
mitochondrial
mitochondrial DNA
outcome
Pathogenesis
pathogenesis of COVID-19
pathway
patients with COVID-19
pharmacological
principle
Profiling
Rapid induction
reduce
response
responses
reveal
SARS-CoV-2
severe lung inflammation
STING
sustained
tissue
Type
Type I IFN
type I IFN responses
type I IFNs
type I interferons
virus propagation
[DOI] 10.1038/s41586-022-04421-w PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41586-022-04421-w PMC 바로가기 [Article Type] Article